‘Drug-eluting Balloon Catheters Market’ Latest Research Report provides an up-to-date analysis of the growth opportunities and trends in the market’s development up to 2032. With a focus on the Drug-eluting Balloon Catheters market, this report offers a thorough examination of the factors driving market growth as well as the restraints influencing its progress. By employing both qualitative and quantitative methodologies, this report presents a comprehensive analysis of the market landscape. It equips companies with valuable insights and data to make informed decisions about their business strategies and identify potential areas for growth. “Ask for Free Sample Report”
Market Overview
The comprehensive analyses of the most recent trends, growth prospects, and market growth drivers are offered to readers of the global market research reports. The COVID-19 effects on the Drug-eluting Balloon Catheters Market are also discussed in detail in the research, along with the market’s predicted compound annual growth rate (CAGR) from 2023 to 2032.
Request To Download Sample of This Strategic Report: –https://reportocean.us/sample-request/report_id/bzwt1944
Global Drug-eluting Balloon Catheters Market is valued at approximately USD 529.4 million in 2021 and is anticipated to grow with a healthy growth rate of more than 8.9% over the forecast period 2022-2029.
Drug-eluting balloon catheters also generally named drug-coated balloon catheters are semi-compliant angioplasty balloons used to deliver anti-proliferative drugs via inflated balloons. It helps in eluting the drug in the targeted vessel and lessens the negative impact of late thrombosis without implanting a permanent foreign object. The balloon technology is based on the theory of targeted medication delivery, which promotes quick artery wall repair and inhibits the growth of smooth muscle cells. The global market growth is likely to be driven by the factors such as increasing cases of peripheral and coronary artery diseases, the growing geriatric population leading to cardiovascular diseases, coupled with the rising need for surgical interventions.
Surging demand for minimally invasive procedures is acting as a catalyzing factor in the market growth across the globe. For instance, as per the NEWS Medical Life Sciences article released in December 2021, drug-coated balloon catheters are highly used with minimally invasive procedures and gaining high traction as replacements over dangerous stent treatment the myocardial infarction. Similarly, according to the NCBI article released in February 2021, the drug-coated balloon offers a wide range of benefits such as minimal side effects than drug-eluting stents, which creates it as a most adaptive therapeutics approach for coronary disease. Accordingly, the high preference towards minimally invasive procedures owing to its leads surgeries less painful and helps in fast recovery. Moreover, the rising introduction of paclitaxel-coated balloon catheter products, as well as the increasing technological advancements in drug-eluting balloon catheters are presenting various lucrative opportunities over the forecasting years.
However, the high cost of development and commercialization of drug-eluting balloons, along with the adverse effects and product recalls are challenging the market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Drug-eluting Balloon Catheters Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the rising incidences of heart diseases and the availability of advanced healthcare facilities. Whereas, the Asia Pacific is also expected to grow with the highest CAGR during the forecast period. Factors such as the rising prevalence of peripheral artery disease, growing patient population, as well as increasing preference for minimally invasive procedures are propelling the demand for drug-eluting balloon catheters in the market space.
Download Sample of This Strategic Report: –https://reportocean.us/sample-request/report_id/bzwt1944
Major market players included in this report are:
- Medtronic Plc
- Koninklijke Philips N.V.
- Boston Scientific Corporation
- BD (Becton, Dickinson and Company)
- B. Braun SE
- Meril Life Sciences Pvt. Ltd.
- BIOTRONIK
- Cordis Corporation
- MicroPort Medical (Group) Co., Ltd.
- Terumo Corporation
Recent Developments in the Market:
- In August 2022, BD unveiled the introduction of the first-in-human prevision trial to assess the safety and effectiveness of the peripheral sirolimus drug-coated balloon (DCB). The purpose of the trials was to evaluate sirolimus’ efficacy as a future therapy option for people with peripheral artery disease (PAD).
- In January 2021, MicroPort Medical (Group) Co., Ltd. announced that they received an EU CE mark for their Reewarm PTX Drug Coated Balloon PTA catheter for femoral popliteal artery indication during percutaneous transluminal angioplasty.
- In November 2020, Boston Scientific Corporation declared that the Ranger, a drug-eluting balloon catheter received approval from U.S. Food & Drug Administration (FDA). The product is specially designed to treat patients with PAD, Proximal Popliteal Artery (PPA),a dn Superficial Femoral Artery (SFA).
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.
Download Sample of This Strategic Report: –https://reportocean.us/sample-request/report_id/bzwt1944
The detailed segments and sub-segment of the market are explained below:
By Drug:
Paclitaxel
Sirolimus
Others
By Indication:
Coronary Intervention
Peripheral Intervention
By End-user:
Hospitals & ASCs
Specialty Clinics and Catheterization Laboratories
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
Request full Report Description, TOC, Table of Figure, Chart, etc. @ –https://reportocean.us/sample-request/report_id/bzwt1944
This report covers several key questions related to the global Drug-eluting Balloon Catheters market, including:
- What can be expected for the Drug-eluting Balloon Catheters market in the next decade?
- What are the primary drivers of growth in the global Drug-eluting Balloon Catheters market?
- Which technologies are likely to experience the most rapid growth, both by market and region?
- How do opportunities within the Drug-eluting Balloon Catheters market vary based on the size of the end market?
- What is the breakdown of Drug-eluting Balloon Catheters by type and application?
- How have recent events such as the COVID-19 pandemic and the Russia-Ukraine conflict impacted the Drug-eluting Balloon Catheters market?
The Key Points Covered in the Table of Contents:
Overview: This section provides a concise summary of the report, offering a high-level understanding of the global Drug-eluting Balloon Catheters Market. It serves as an introduction, providing insights into the nature and contents of the research study.
Market Analysis: The research study accurately and reliably forecasts the market share of key segments within the Drug-eluting Balloon Catheters Market. This analysis enables industry participants to make strategic investments in the significant growth areas of the Drug-eluting Balloon Catheters Market.
Analysis of Leading Players’ Strategies: Market participants can utilize this report to gain a competitive advantage over their rivals in the Drug-eluting Balloon Catheters Market. It offers an in-depth analysis of the strategies employed by leading players, enabling others to develop effective strategies and stay ahead in the market.
Regional Growth Analysis: The report covers all major regions and countries relevant to the Drug-eluting Balloon Catheters Market. The regional analysis facilitates market players in identifying untapped regional markets, devising unique regional strategies, and comparing the growth patterns across different regions.
Market Forecasts: Purchasers of this report gain access to precise and validated estimations of the overall market size in terms of both value and volume. The study also includes comprehensive forecasts for consumption, production, sales, and other pertinent factors related to the Drug-eluting Balloon Catheters Market.
Our Drug-eluting Balloon Catheters Market Report is a comprehensive analysis of the market, providing valuable insights for businesses looking to invest in this industry.
Request Full Report –https://reportocean.us/sample-request/report_id/bzwt1944
About Report Ocean:
We are the best market research reports provider in the industry. Report Ocean believes in providing quality reports to clients to meet the top line and bottom-line goals which will boost your market share in today’s competitive environment. Report Ocean is a ‘one-stop solution’ for individuals, organizations, and industries that are looking for innovative market research reports.
Get in Touch with Us:
Report Ocean:
Email: sales@reportocean.com
Address: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 – UNITED STATES
Tel:+1 888 212 3539 (US – TOLL FREE)
Website: https://reportocean.us/